IONS - Company ID 0000874015
The table below shows IONIS PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $372.26M | $242.08M | $399.27M | $276.47M | $869.19M | $397.66M |
| Short-term investments | $2.31B | $2.06B | $1.93B | $1.71B | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $10.05M | $12.51M | $28.43M | $22.03M | $24.81M | $21.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.99B |
| $2.62B |
| $2.64B |
| $2.20B |
| $2.35B |
| $2.13B |
| Property, plant & equipment | $123.05M | $94.25M | $71.04M | $74.29M | $178.07M | $181.08M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B |
| Accounts payable | $28.08M | $42.96M | $26.03M | $17.92M | $11.90M | $17.20M |
| Total current liabilities | $781.57M | $309.32M | $448.09M | $311.56M | $240.55M | $583.25M |
| Long-term debt | $1.33B | $1.20B | $1.24B | $1.18B | - | - |
| Total liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.55B |
| Retained earnings | -$2.63B | -$2.25B | -$1.80B | -$1.43B | -$1.16B | -$1.25B |
| Total equity | $489.09M | $588.35M | $386.69M | $572.89M | $771.74M | $843.35M |